Pharmacologic evaluation of pressor and visceromotor reflex responses to bladder distension

Neurourology and Urodynamics

Volumn 27, Issue 3, 2008, Pages 249-253

  Su, Xin ^a   Riedel, Erin S ^a   Leon, Lisa A ^a   Laping, Nicholas J ^a  

^a GLAXOSMITHKLINE   (United States)

Author keywords

Bladder nociception; Pressor response; Urinary bladder distension; Visceromotor reflex

Indexed keywords

3,4 DICHLORO N METHYL N [2 (1 PYRROLIDINYL)CYCLOHEXYL]BENZENEACETAMIDE; ISOFLURANE; KAPPA OPIATE RECEPTOR; MEXILETINE; MORPHINE; MU OPIATE RECEPTOR; MUSCARINIC RECEPTOR; NAPROXEN; OXYBUTYNIN; PROSTAGLANDIN SYNTHASE; SODIUM CHANNEL;

ABDOMINAL WALL MUSCULATURE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTERY CATHETERIZATION; ARTICLE; BLADDER; BLADDER DISTENSION; CANNULATION; CAROTID ARTERY; CONTROLLED STUDY; ELECTRODE; EXPERIMENTAL MODEL; FEMALE; JUGULAR VEIN; MYOELECTRICITY; NOCICEPTIVE STIMULATION; NONHUMAN; PRESSOR RESPONSE; PRESSORECEPTOR REFLEX; RAT; SPRAGUE DAWLEY RAT; VISCEROMOTOR REFLEX;

3,4-DICHLORO-N-METHYL-N-(2-(1-PYRROLIDINYL)-CYCLOHEXYL)-BENZENEACETAMIDE, (TRANS)-ISOMER; ANALGESICS; ANALGESICS, NON-NARCOTIC; ANALGESICS, OPIOID; ANIMALS; BLOOD PRESSURE; CARDIOVASCULAR SYSTEM; CYCLOOXYGENASE INHIBITORS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; MANDELIC ACIDS; MEXILETINE; MODELS, ANIMAL; MORPHINE; MUSCARINIC ANTAGONISTS; MUSCLE CONTRACTION; MUSCLE, SKELETAL; NAPROXEN; NOCICEPTORS; PRESSURE; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, MUSCARINIC; RECEPTORS, OPIOID, KAPPA; RECEPTORS, OPIOID, MU; REFLEX; SODIUM CHANNEL BLOCKERS; SODIUM CHANNELS; URINARY BLADDER;

EID: 40849096352     PISSN: 07332467     EISSN: 15206777     Source Type: Journal    
DOI: 10.1002/nau.20469     Document Type: Article

References (38)

1. Woodworth ES, Sherrington CS. A pseudaffective reflex and its spinal path. J Physiol (Lond) 1904;31:234-43.
2. Ness TJ, Gebhart GF. Colorectal distension as a noxious visceral stimulus: Physiologic and pharmacologic characterization. Brain Res 1988;450:153-69.
3. Ness TJ, Gebhart GF. Visceral pain: A review of experimental studies. Pain 1990;41:167-234.
4. Ness TJ, Lewis-Sides A, Castroman P. Characterization of pressor and visceromotor reflex responses to bladder distention in rats: Sources of variability and effect of analgesics. J Urol 2001;165:968-74.
5. Cruz Y, Downie JW. Abdominal muscle activity during voiding in female rats with normal or irritated bladder. Am J Physiol Regul Integr Comp Physiol 2005;290:R1436-45.
6. Bors E, Blinn KA. Abdominal electromyography during micturition. Calif Med 1965;102:17-22.
7. Shafik A. Straining and its role in micturition. Urology 2003;62:199-200.
8. McMahon SB, Dmitrieva N, Koltzenburg M. Visceral pain. Br J Anaesth 1995;75:132-44.
9. Ness TJ, Metcalf AM, Gebhart GF. A psychophysiological study in humans using phasic colonic distension as a noxious visceral stimulus. Pain 1990;43:377-86.
10. Ness TJ, Richter HE, Varner RE, et al. A psychophysical study of discomfort produced by repeated filling of the urinary bladder. Pain 1998;76:61-9.
11. Randich A, Uzzell T, Cannon R, et al. Inflammation and enhanced nociceptive responses to bladder distension produced by intravesical zymosan in the rat. BMC Urol 2006;6:1-7.
12. Castroman PJ, Ness TJ. Ketamine, an N-methyl-D-aspartate receptor antagonist, inhibits the reflex responses to distension of the rat urinary bladder. Lab Inv 2002;96:1401-9.
13. Castroman PJ, Ness TJ. Vigor of visceromotor responses to urinary bladder distension in rats increases with repeated trials and stimulus intensity. Neurosci Lett 2001;306:97-100.
14. Danzebrink RM, Green SH, Gebhart GF. Spinal mu and delta but not kappa opioid receptor agonists attenuate responses to noxious colorectal distension in the rat. Pain 1995;63:39-47.
15. Harada Y, Nishioka K, Kitahata LM, et al. Visceral antinociceptive effects of spinal clonidine combined with morphine, [D-Pen2, D-Pen5] enkephalin, or U50,488H. Anesthesiology 1995;83:344-52.
16. Harada Y, Nishioka K, Kitahata LM, et al. Contrasting actions of intrathecal U50,488H, morphine, or [D-Pen2, D-Pen5] enkephalin, or intravenous U50,488H on visceromotor response to colorectal distension in the rat. Anesthesiology 1995;83:336-43.
17. Su X, Sengupta JN, Gebhart GF. Effect of kappa opioid receptor-selective agonists on responses of pelvic nerve afferents to noxious colorectal distension. J Neurophysiol 1997;78:1003-12.
18. Su X, Joshi SK, Kardos S, et al. Sodium channel blocking actions of the κ-opioid receptor agonist U50,488 contribute to its visceral antinociceptive effects. J Neurophysiol 2002;87:1271-9.
19. Yarker YE, Goa KL, Fitton A, et al. A review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic use in detrusor instability. Drug Ageing 1995;6:243-62.
20. DeLaet K, DeWachter D, Wyndaele JJ. Systemic oxybutynin decreases afferent activity of the pelvic nerve of the rat: New insights into the working mechanism of antimuscarinics. Neurourol Urodyn 2006;25:156-61.
21. Takagi-Matsumoto H, Ng B, Tsukimi Y, et al. Effects of NSAIDs on bladder function in normal and cystitis rats: A comparison study of aspirin, indomethacin, and ketoprofen. J Pharmacol Sci 2004;95:458-65.
22. Angelico P, Guarneri L, Velasco C, et al. Effect of cyclooxygenase inhibitors on the micturition reflex in rats: Correlation with inhibition of cyclooxygenase isozymes. Brit J Urol 2006;97:837-46.
23. Su X, Gebhart GF. Mechanosensitive pelvic nerve afferent fibers innervating the colon of the rat are polymodal in character. J Neurophysiol 1998;80:2632-44.
24. Su X, Sengupta JN, Gebhart GF. Effects of opioids on mechanosensitive pelvic nerve afferent fibers innervating the urinary bladder of the rat. J Neurophysiol 1997;77:1566-80.
25. Ness TJ. Intravenous lidocaine inhibits visceral nociceptive reflexes and spinal neurons in the rat. Anesthesiology 2000;92:1685-91.
26. Sengupta JN, Su X, Gebhart GF. Kappa, but not mu or delta opioids attenuate responses to distension of afferent fibers innervating the rat colon. Gastroenterology 1996;111:968-80.
27. Andersson KE, Wein AJ. Pharmacology of the lower urinary tract: Basis for current and future treatments of urinary incontinence. Pharmacol Rev 2004;56:581-631.
28. Kim Y, Yoshimura N, Masuda H, et al. Antimuscarinic agents exhibit local inhibitory effects on muscarinic receptors in bladder-afferent pathways. Urology 2005;65:238-42.
29. Seifert TR, Joshi SK, Honore P, et al. Effects of standard analgesics in colorectal distention-induced visceral pain. Soc Neurosci Abs 2005. 169.6.
30. Erickson DR, Davies MF. Interstitial cystitis. Int Urogynecol J 1998;9:174-83.
31. Lukban JC. Current status in the pharmacological management of interstitial cystitis. Expert Opin Pharmacother 2003;4:1967-75.
32. Ouslander JG. Management of overactive bladder. N Engl J Med 2004;350:786-99.
33. Andersson KE. Current concepts in the treatment of disorders of micturition. Drugs 1988;35:477-94.
34. Perrot S, Guilbaud G, Kayser V. Differential behavioral effects of peripheral and systemic morphine and naloxone in a rat model of repeated acute inflammation. Anesthesiology 2001;94:870-5.
35. Burton MB, Gebhart GF. Effects of kappa-opioid receptor agonists on responses to colorectal distension in rats with and without acute colonic inflammation. J Pharmcol Exp Ther 1998;285:707-15.
36. Stoffel EC, Ulibarri CM, Folk JE, et al. Gonadal hormone modulation of mu, kappa, and delta opioid antinociception in male and female rats. J Pain 2005;6:261-74.
37. Nakamura S, Atsuta Y. Effect of sodium channel blocker (mexiletine) on pathological ectopic firing pattern in a rat chronic constriction nerve injury model. J Orthop Sci 2005;10:315-20.
38. Modiri AR, Alberts P, Gillberg PG. Effect of muscarinic antagonists on micturition pressure measured by cystometry in normal, conscious rats. Urology 2002;59:963-8.